Michael G. Pfreundschuh
Kirrberger Str. 100
Homburg, SL 66421, Germany
Homburg, SL 66421, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 142 publications
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma.
Journal: Annals of hematology
Published: April 20, 2024
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
Journal: EJHaem
Published: September 30, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigens.
Journal: EJHaem
Published: March 14, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials.
Journal: The Lancet. Haematology
Published: October 13, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 03, 2021
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma.
Journal: European journal of haematology
Published: July 29, 2020
Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
Journal: Frontiers in oncology
Published: July 05, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma.
Journal: Nature communications
Published: November 15, 2019
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.
Journal: Haematologica
Published: October 28, 2019
Last Updated: 09/26/2026